Buy caberlin 0.5 mg is an ergot-derived drug that is used to treat Prolactinoma, Cushing's disease and other pituitary adenomas. It is a dopamine receptor agonist on D2 receptors. Due to its inhibitory effect on prolactin cells, it is successfully used to treat disorders of increased prolactin levels. Since its inception in 1981 it has replaced bromocriptine as the first-line drug in the treatment of Prolactinoma due to less severe side effects and higher affinity for dopamine D2 receptors.